These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16871456)

  • 1. American Society of Clinical Oncology--42nd annual meeting. Ovarian cancer, solid tumors, neuroendocrine tumors and lymphoma. 2-6 June 2006, Atlanta, GA, USA.
    Searle B; Chan D
    IDrugs; 2006 Aug; 9(8):529-31. PubMed ID: 16871456
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Clinical Oncology--42nd annual meeting. Epigenetic targeting and reports on cancer-related therapies. 2-6 June 2006, Atlanta, GA, USA.
    Searle B
    IDrugs; 2006 Aug; 9(8):526-8. PubMed ID: 16871455
    [No Abstract]   [Full Text] [Related]  

  • 3. American Society of Clinical Oncology--42nd annual meeting. Current approaches to lung cancer therapy. 2-6 June 2006, Atlanta, GA, USA.
    Chan D; Cleverley J
    IDrugs; 2006 Aug; 9(8):523-5. PubMed ID: 16871454
    [No Abstract]   [Full Text] [Related]  

  • 4. 42nd annual meeting of the American Society of Clinical Oncology June 2006, Atlanta, GA.
    Schwab C; Shivakumar L
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):16-24. PubMed ID: 16879765
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.
    Puglisi F; Andreetta C; Fasola G
    Expert Opin Pharmacother; 2006 Nov; 7(16):2309-18. PubMed ID: 17059386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology--42nd annual meeting. 2-6 June 2006, Atlanta, GA, USA.
    Chan D; Cleverley J; Searle B
    IDrugs; 2006 Aug; 9(8):517-9. PubMed ID: 16871452
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA, June 2006.
    Clin Breast Cancer; 2006 Oct; 7(4):306-14. PubMed ID: 17092397
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology 2011 Annual Meeting update: summary of selected gynecologic cancer abstracts.
    Tewari KS; Monk BJ
    Gynecol Oncol; 2011 Aug; 122(2):209-12. PubMed ID: 21763890
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Oberstein PE; Saif MW
    JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology--42nd annual meeting. Poster presentations on leukemia and cytotoxic chemotherapy. 2-6 June 2006, Atlanta, GA, USA.
    Cleverley J
    IDrugs; 2006 Aug; 9(8):520-2. PubMed ID: 16871453
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on novel therapies for pancreatic neuroendocrine tumors: 2013.
    Dimou A; Syrigos KN; Saif MW
    JOP; 2013 Jul; 14(4):377-80. PubMed ID: 23846931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA; June 2-6, 2006.
    Reddy GK; Tyagi P
    Clin Genitourin Cancer; 2006 Jun; 5(1):18-22. PubMed ID: 16859574
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy: Blockade of IGF-1R-not effective in neuroendocrine tumours.
    Libutti SK
    Nat Rev Endocrinol; 2013 Jul; 9(7):389-90. PubMed ID: 23732282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence for Taxotere treatment with solid tumors].
    Saeki T; Takashima S; Sasaki Y; Ito K; Igarashi T; Minami H; Fujii H; Ishizawa K; Kubota K; Imoto S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1288-93. PubMed ID: 10945028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are targeted therapies a consideration in poorly differentiated neuroendocrine tumors?
    Sorscher S
    Oncologist; 2013; 18(11):1239. PubMed ID: 24218001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues.
    Khagi S; Saif MW
    JOP; 2014 Jul; 15(4):295-8. PubMed ID: 25076324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the activity of temsirolimus in neuroendocrine cancer.
    O'Donnell PH; Ratain MJ
    Br J Cancer; 2007 Jan; 96(1):177; author reply 178-9. PubMed ID: 17164757
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II oncology trials: let's be positive.
    Ratain MJ
    Clin Cancer Res; 2005 Aug; 11(16):5661-2. PubMed ID: 16115898
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of lymphoma.
    Abbott BL
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):30-2. PubMed ID: 16879767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.